Thermo Fisher Scientific Inc., Abbott (AlereInc), and BD–Considerable Market Players inE. coli Testing Market
- coli are responsible for various infectious diseases such as urinary tract infection, gastrointestinal diseases, and food poisoning among others. The very first step to diagnose a diseases is bacterial identification. A physician will send samples such as saliva, blood, urine or stool for diagnosis. It is important to identify the root cause of infection. Also, the E. coli causes food and water borne infections, therefore, the E. coli test are conducted widely across the world. Factors such as of increasing E. coli testing, growing product innovation, and rising research activities are expected to propel the growth of the market. On the other hand, testing challenges is the major factor, which is expected to hinder the market growth during the forecast period.
The most notable market participants are Bio-Rad Laboratories, Inc, Pro-Lab Diagnostics, Inc., Abbott (Alere Inc.), IDEXX Laboratories, Inc., Meridian Bioscience, Inc., BD, Thermo Fisher Scientific, Inc., CPI International, Biomerieux Inc., Hologic, Inc.occupyinga considerable share of the market owing to their offerings to the market.
The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as product launches. Whereas, the inorganic strategies such as partnership, and collaborations, were widely seen in the E. coli testing market. Majority of the market leaders are involved in inorganic activities such as merger and acquisition in order to improve their performance and consolidate market position.
These strategies are helping major players to strengthen their market positions along with widening their geographic footprints.Few of the important key developments from the industry are mentioned below:
|Oct-2019||Bio-Rad Laboratories, Inc. has announced the launch of its dd-Check STEC Solution for detecting virulence genes from Shiga n toxin-producing Escherichia coli (STEC). It is the first commercially available droplet digital PCR solution for detecting pathogenic STEC||North America|
|Mar-2019||Meridian acquired GenePOC’s molecular diagnostics business portfolio. The main objective for the acquisition is to use the benefit of GenePOC’s rapid, high-quality diagnostics testing to patients, supporting diagnosis and guidance towards targeted therapeutic decisions for infectious diseases.||North America|
|Aug-2018||Neogen acquired the stock of Clarus Labs, Inc., a manufacturer of water testing products. Neogen has distributed Clarus’ Colitag water test to the food and beverage industries since 2004 and this acquisition gives the Company access to sell this product to new markets. The acquisition include the patented Colitag water test, which detect hazardous coliform bacteria (i.e., bacteria normally found in the intestine), including E. coli, in water.||North America|
|Sep-2017||Abbott announced the acquisition of Alere, the point of care testing company based in Massachusetts, considerably advancing its diagnostics presence and leadership. Abbott’s total diagnostics sales will exceed $7 billion after the closure.||North America|
|Nov-2015||bioMérieux introduced GENE-UP, its new PCR-based molecular diagnostic system for the detection of microorganisms (bacteria and viruses). fThis platform enable the microbiological control of food, raw materials and the production environment for customers in the agri-food sector||North America|